Zusammenfassung
Hintergrund
Biopsien und Punktionen an Niere, Prostata und Harnblase gehören zu den häufigsten Eingriffen in der Urologie. Eine korrekte Indikationsstellung, Vorbereitung und Durchführung ist wichtig für komplikationsarme Ergebnisse.
Ziel
In dieser Übersichtsarbeit wird das Komplikationsmanagement bei den Standardeingriffen Biopsie der Prostata und den Punktionen von Niere und Harnblase dargestellt.
Material und Methoden
Der Beitrag liefert eine selektive Literaturrecherche mit vorrangiger Berücksichtigung systematischer Übersichtarbeiten und größerer Fallstudien.
Ergebnisse
Obwohl die Komplikationsraten generell niedrig erscheinen, können bestimmte Umstände, wie Antikoagulation, anatomische Veränderungen, Begleitmorbiditäten oder Antibiotikaresistenzen eine bedeutende Rolle spielen und die Komplikationshäufigkeiten erhöhen. Insbesondere Komplikationen wie Hämaturie und Verletzung von Nachbarorganen werden in der Literatur beschrieben.
Diskussion
Biopsien und Punktionen an Niere, Prostata und Harnblase können in der Regel komplikationsarm durchgeführt werden, wenn allgemeine und spezifische Faktoren in der Planung der Intervention und der Vermeidung von Komplikationen berücksichtigt werden.
Abstract
Background
Biopsies of the kidney, prostate and urinary bladder are amongst the most frequent interventions in urology. A correct indication, preparation and performance are important to achieve good results and low complication rates.
Objectives
In this review complication management in biopsies of the kidney, prostate and urinary bladder are discussed.
Materials and methods
A selective search of the literature, with emphasis on systematic reviews and larger cohort studies was performed.
Results
Complication rates are generally low. However, certain factors such as coagulation disorders, anatomical malformations, accompanying morbidities or antibiotic resistance may play a significant role and increase rates of complications. Especially complications such as hematuria and injury of contiguous organs are described in the literature.
Discussion
Biopsies of the kidney, prostate and urinary bladder can be performed with low complication rates if general and specific factors in the planning of the intervention and prevention of complications are considered.
Literatur
Wagenlehner FM, Oostrum E van, Tenke P et al (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521–527
Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892
Rosario DJ, Lane JA, Metcalfe C et al (2012) Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 344:7894
Janssens U (2012) Regionale und systemische Komplikationen. In: Anheuser P, Steffens J (Hrsg) Risiken und Komplikationen in der Urologie. Thieme, Stuttgart, S 26–35
Hoffmeister HM,·Bode C,·Darius H et al (2010) Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. Kardiologe 4:365–374
Loeb S (2012) Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109(12):1785–1786
Loeb S, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186(5):1830–1834
Loeb S, Heuvel S van den, Zhu X et al (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61(6):1110–1114
Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183(3):963–968
Nam RK, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):12–17
Wagenlehner FM, Pilatz A, Waliszewski P et al (2014) Reducing infection rates after prostate biopsy. Nat Rev Urol 11(2):80–86
Steensels D, Slabbaert K, De Wever L et al (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy – should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18(6):575–581
Taylor AK, Zembower TR, Nadler RB et al (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187(4):1275–1279
Cohen AH, Nast CC, Adler SG, Kopple JD (1989) Clinical utility of kidney biopsies in the diagnosis and management of renal disease. Am J Nephrol 9(4):309–315
Koch K-M (2000) Klinische Nephrologie. Urban & Fischer, München
Kuhlmann U, Walb D, Luft FC (1998) Nephrologie. Thieme, Stuttgart
Radecka E, Magnusson A (2004) Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol 45(2):184–188
Corapi KM, Chen JL, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60(1):62–73
Marwah DS, Korbet SM (1996) Timing of complications in percutaneous renal biopsy: what is the optimal period of observation? Am J Kidney Dis 28(1):47–52
Grabe M (chairman) BM, Bjerklund-Johansen TE, Botto H et al (2010) Guidelines on urological infections. In: EAU (ed) European association of urology guidelines. European Association of Urology, Arnhem, pp 1–110
Wagenlehner FME (2012) Komplikationen bei Punktion und Injektion. In: Anheuser P, Steffens J (Hrsg) Risiken und Komplikationen in der Urologie. Thieme, Stuttgart, S 78–82
Lee KL, Stoller ML (2007) Minimizing and managing bleeding after percutaneous nephrolithotomy. Curr Opin Urol 17(2):120–124
Ray AA, Chung DG, Honey RJ (2009) Percutaneous nephrolithotomy in the prone and prone-flexed positions: anatomic considerations. J Endourol 23(10):1607–1614
Saxby MF (1996) Biliary peritonitis following percutaneous nephrolithotomy. Br J Urol 77(3):465–466
Traxer O (2009) Management of injury to the bowel during percutaneous stone removal. J Endourol 23(10):1777–1780
El-Nahas AR, Mansour AM, Ellaithy R, Abol-Enein H (2008) Case report: conservative treatment of liver injury during percutaneous nephrolithotomy. J Endourol 22(8):1649–1652
Desai AC, Jain S, Benway BM et al (2010) Splenic injury during percutaneous nephrolithotomy: a case report with novel management technique. J Endourol 24(4):541–545
Shaban A, Kodera A, El Ghoneimy MN et al (2008) Safety and efficacy of supracostal access in percutaneous renal surgery. J Endourol 22(1):29–34
Maheshwari PN, Mane DA, Pathak AB (2009) Management of pleural injury after percutaneous renal surgery. J Endourol 23(10):1769–1772
Beetz R, Wagenlehner F (2012) Diagnostics and therapy of urinary tract infections. Urologe A 52(1):21–32
Ringert RH, Gross AJ (1996) Bladder catheter or suprapubic fistula? Indications and contraindications. Langenbecks Arch Chir Suppl Kongressbd 113:713–717
Cho KH, Doo SW, Yang WJ et al (2010) Suprapubic cystostomy: risk analysis of possible bowel interposition through the percutaneous tract by computed tomography. Korean J Urol 51(10):709–712
Einhaltung ethischer Richtlinien
Interessenkonflikt. F.M.E. Wagenlehner, W. Weidner, T. Diemer und B. Altinkilic geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagenlehner, F., Weidner, W., Diemer, T. et al. Biopsie der Prostata und Punktion der Niere und Blase. Urologe 53, 683–688 (2014). https://doi.org/10.1007/s00120-014-3478-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-014-3478-4